Open to Enrollment Studies | Research | Services | KRHC ...
https://www.krh.org/krhc/services/research/open-to-enrollment-studies
For more information on the current trials, visit mtcancer.org. NOVARTIS CLEE011G2301 (EARLEE-1) A phase III, multicenter, randomized, double-blind, placebo-controlled study to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, high-risk early ...
DA: 41 PA: 30 MOZ Rank: 57